SGMO Sangamo Therapeutics Inc. Operating Profitability

SGMO (Sangamo Therapeutics Inc.) - company brandmark

Sangamo Therapeutics (SGMO) is scaling its business through the licensing of DNA designs, receiving upfront payments from industry behemoths. Patent superiority in gene editing provides the company with pricing power. The anticipation of clinical results and partner payments defines current prospects. The -273.10 mark reflects fresh data, which is visualized by the operating profit margin trend.

SGMO: Sangamo Therapeutics Inc. Operating Return on Sales 07/04/2022 - 05/09/2026

Financial and market metric breakdowns for Sangamo Therapeutics (SGMO)

- share price and consensus valuation forecast:
- cash and cash flow statistics:
Initial company analysis:Sangamo BioSciences, SGMO
Brand item of Sangamo BioSciences

Sangamo Therapeutics (SGMO) minimizes shortage risks and maintains cost stability through the diversification of its bio-raw material suppliers. The operating margin trend illustrates the efficiency of managing these expenses relative to revenue. This metric measures the share of core business profit before interest and taxes, revealing the actual profitability of operations. Daily monitoring eliminates the uncertainty of quarterly reports by identifying hidden fluctuations in yield. This tool allows for an objective assessment of the asset's business model sustainability.

Analysis of competing companies

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Nautilus Biotechnology - Operating Margin|Operating Profit Rate MGX (Metagenomi, Inc)|DTIL: Operating Margin|GBIO: Operating Profit Ratio|Operating Profitability Boundless Bio Inc.|Operating Sales Margin Exicure (XCUR)|Operating Margin IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operating Profit Rate|Mustang Bio, Inc. - Operating Sales Margin|RNAZ - Operating Sales Margin|BNGO: Operating Sales Margin|APDN (Applied DNA Sciences Inc) - Return on Sales by Operating Profit|BLUE (Bluebird Bio) - Operating Sales Margin|ImmunoPrecise Antibodies Ltd - Operating Profit Rate|OMGA (Omega Therapeutics Inc) - Operating Margin|Operating Profitability OMIC|Operating Profitability Regulus Therapeutics Inc. (RGLS)|Operating Sales Margin Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Operating Sales Margin|Operating Profit Rate TCON|UBX - Operating Profitability